Safety and Efficacy Study of SHP465 in Children and Adolescents Aged 6-17 Years With Attention-Deficit Hyperactivity Disorder (ADHD)
Public ClinicalTrials.gov record NCT02466425. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 3, Randomized, Double-blind, Multi-center, Placebo Controlled, Dose-Optimization, Safety and Efficacy Study of SHP465 in Children and Adolescents Aged 6-17 Years With Attention-Deficit Hyperactivity Disorder (ADHD)
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The study is designed to evaluate the efficacy and safety of SHP465 in the treatment of ADHD in children and adolescents (aged 6-17 years). The primary objective of this study is to evaluate the efficacy of SHP465 administered as a daily morning dose compared to placebo in the treatment of children and adolescents (6-17 years of age inclusive) diagnosed with ADHD.
Study identification
- NCT ID
- NCT02466425
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 264 participants
Conditions and interventions
Eligibility (public fields only)
- Age range
- 6 Years to 17 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 18, 2015 (Actual)
- Primary completion
- Feb 16, 2016 (Actual)
- Completion
- Feb 16, 2016 (Actual)
- Last update posted
- Jun 3, 2021
2015 – 2016
United States locations
- U.S. sites
- 36
- U.S. states
- 19
- U.S. cities
- 34
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Harmonex Neuroscience Research | Dothan | Alabama | 36303 | — |
| Nrc Research Institute | Orange | California | 92868 | — |
| Pcsd Feighner Research | San Diego | California | 92108 | — |
| Encompass Clinical Research | Spring Valley | California | 91978 | — |
| Elite Clinical Trials, Inc | Wildomar | California | 92595 | — |
| McB Clinical Research Centers | Colorado Springs | Colorado | 80910 | — |
| Florida Clinical Research Center, Llc | Bradenton | Florida | 34201 | — |
| Sarkis Clinical Trials | Gainesville | Florida | 32607 | — |
| Clinical Neuroscience Solutions, Inc. | Jacksonville | Florida | 32256 | — |
| Medical Research Group of Central Florida | Orange City | Florida | 32763 | — |
| Clinical Neuroscience Solutions, Inc. | Orlando | Florida | 32801 | — |
| Miami Research Associates, Llc | South Miami | Florida | 33143 | — |
| Janus Center For Psychiatric Research | West Palm Beach | Florida | 33407 | — |
| Northwest Behavioral Research Center | Marietta | Georgia | 30060 | — |
| Capstone Clinical Research | Libertyville | Illinois | 60048 | — |
| Baber Research Group Inc | Naperville | Illinois | 60563 | — |
| Psychiatric Associates | Overland Park | Kansas | 66211 | — |
| Louisiana Research Associates, Inc | New Orleans | Louisiana | 70114 | — |
| Rochester Center For Behavioral Medicine | Rochester Hills | Michigan | 48307 | — |
| Psychiatric Care and Research Center | O'Fallon | Missouri | 63368 | — |
| Midwest Research Group | Saint Charles | Missouri | 63304 | — |
| Center For Psychiatry and Behavioral Medicine | Las Vegas | Nevada | 89128 | — |
| Midwest Clinical Research Center | Dayton | Ohio | 45417 | — |
| Tulsa Clinical Research, Llc | Tulsa | Oklahoma | 74104 | — |
| Oregon Center For Clinical Investigations, Inc | Salem | Oregon | 97301 | — |
| Omega Medical Research | Warwick | Rhode Island | 02886 | — |
| Rainbow Research | Barnwell | South Carolina | 29812 | — |
| Coastal Carolina Research Center | Mt. Pleasant | South Carolina | 29464 | — |
| Clinical Neuroscience Solution, Inc | Memphis | Tennessee | 38119 | — |
| Futuresearch Trials of Dallas, Lp | Dallas | Texas | 75231 | — |
| Bayou City Research | Houston | Texas | 77007 | — |
| Red Oak Psychiatry Associates, Pa | Houston | Texas | 77090 | — |
| Houston Clinical Trials, Llc | Houston | Texas | 77098 | — |
| Westex Clinical Investigations | Lubbock | Texas | 79423 | — |
| Research Across America | Plano | Texas | 75093 | — |
| Eastside Therapeutic Resource | Kirkland | Washington | 98033 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02466425, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 3, 2021 · Synced Oct 20, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT02466425 live on ClinicalTrials.gov.